Show simple item record

dc.contributor.authorKelley, Erin
dc.contributor.authorDriebe, Elizabeth
dc.contributor.authorEtienne, Kizee
dc.contributor.authorBrandt, Mary
dc.contributor.authorSchupp, James
dc.contributor.authorGillece, John
dc.contributor.authorTrujillo, Jesse
dc.contributor.authorLockhart, Shawn
dc.contributor.authorDeak, Eszter
dc.contributor.authorKeim, Paul
dc.contributor.authorEngelthaler, David
dc.date.accessioned2016-05-20T08:57:38Z
dc.date.available2016-05-20T08:57:38Z
dc.date.issued2014en
dc.identifier.citationKelley et al. BMC Microbiology 2014, 14:125 http://www.biomedcentral.com/1471-2180/14/125en
dc.identifier.doi10.1186/1471-2180-14-125en
dc.identifier.urihttp://hdl.handle.net/10150/610059
dc.description.abstractBACKGROUND:Cryptococcus gattii has been the cause of an ongoing outbreak starting in 1999 on Vancouver Island, British Columbia and spreading to mainland Canada and the US Pacific Northwest. In the course of the outbreak, C. gattii has been identified outside of its previously documented climate, habitat, and host disease. Genotyping of C. gattii is essential to understand the ecological and geographical expansion of this emerging pathogen.METHODS:We developed and validated a mismatch amplification mutation assay (MAMA) real-time PCR panel for genotyping C. gattii molecular types VGI-VGIV and VGII subtypes a,b,c. Subtype assays were designed based on whole-genome sequence of 20 C. gattii strains. Publically available multilocus sequence typing (MLST) data from a study of 202 strains was used for the molecular type (VGI-VGIV) assay design. All assays were validated across DNA from 112 strains of diverse international origin and sample types, including animal, environmental and human.RESULTS:Validation revealed each assay on the panel is 100% sensitive, specific and concordant with MLST. The assay panel can detect down to 0.5 picograms of template DNA.CONCLUSIONS:The (MAMA) real-time PCR panel for C. gattii accurately typed a collection of 112 diverse strains and demonstrated high sensitivity. This is a time and cost efficient method of genotyping C. gattii best suited for application in large-scale epidemiological studies.
dc.language.isoenen
dc.publisherBioMed Centralen
dc.relation.urlhttp://www.biomedcentral.com/1471-2180/14/125en
dc.rights© 2014 Kelley et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0).en
dc.rights.urihttps://creativecommons.org/licenses/by/2.0/
dc.subjectCryptococcus gattiien
dc.subjectGenotypingen
dc.subjectReal-time PCRen
dc.subjectEpidemiologyen
dc.titleReal-time PCR assays for genotyping of Cryptococcus gattii in North Americaen
dc.typeArticleen
dc.identifier.eissn1471-2180en
dc.contributor.departmentThe Translational Genomics Research Institute, 3051 W. Shamrell Blvd. Ste. 106, Flagstaff, AZ 86001, USAen
dc.contributor.departmentCenters for Disease Control and Prevention, Atlanta, GA, USAen
dc.contributor.departmentDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USAen
dc.contributor.departmentCenter for Microbial Genetics and Genomics, Northern Arizona University, Flagstaff, AZ, USAen
dc.identifier.journalBMC Microbiologyen
dc.description.collectioninformationThis item is part of the UA Faculty Publications collection. For more information this item or other items in the UA Campus Repository, contact the University of Arizona Libraries at repository@u.library.arizona.edu.en
dc.eprint.versionFinal published versionen
refterms.dateFOA2018-09-11T10:44:23Z
html.description.abstractBACKGROUND:Cryptococcus gattii has been the cause of an ongoing outbreak starting in 1999 on Vancouver Island, British Columbia and spreading to mainland Canada and the US Pacific Northwest. In the course of the outbreak, C. gattii has been identified outside of its previously documented climate, habitat, and host disease. Genotyping of C. gattii is essential to understand the ecological and geographical expansion of this emerging pathogen.METHODS:We developed and validated a mismatch amplification mutation assay (MAMA) real-time PCR panel for genotyping C. gattii molecular types VGI-VGIV and VGII subtypes a,b,c. Subtype assays were designed based on whole-genome sequence of 20 C. gattii strains. Publically available multilocus sequence typing (MLST) data from a study of 202 strains was used for the molecular type (VGI-VGIV) assay design. All assays were validated across DNA from 112 strains of diverse international origin and sample types, including animal, environmental and human.RESULTS:Validation revealed each assay on the panel is 100% sensitive, specific and concordant with MLST. The assay panel can detect down to 0.5 picograms of template DNA.CONCLUSIONS:The (MAMA) real-time PCR panel for C. gattii accurately typed a collection of 112 diverse strains and demonstrated high sensitivity. This is a time and cost efficient method of genotyping C. gattii best suited for application in large-scale epidemiological studies.


Files in this item

Thumbnail
Name:
1471-2180-14-125.pdf
Size:
649.3Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

© 2014 Kelley et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0).
Except where otherwise noted, this item's license is described as © 2014 Kelley et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0).